Analytics cookies help us understand what works in the catalog. Accept all, reject non-essential ones, or choose categories below. Privacy policy
The only human cathelicidin: an innate-immunity peptide that neutrophils and skin use to meet microbes. It is studied for immune defence and wound healing.
Size: 5 mg
No published analyses yet.
Research, properties and limitations
AI can make mistakes
Titration schedule · reference
The information below is provided from public sources for reference only. It is not advice or instructions for use; products are intended for laboratory research only and not for human consumption.
| Period / condition | Dose | Escalation |
|---|---|---|
| Start | 100 mcg subcutaneously, once daily | Starting dose |
| Maintenance | 100–300 mcg subcutaneously, once daily | Increase if needed |
| Upper range | up to 400 mcg subcutaneously per day; 4–12 week cycle | Maximum in this schedule |
Research overview · reference
Below is a short summary of what the authors of published studies reported. It is not medical advice or instructions for use; products are intended for laboratory research only and not for human consumption.
| Effect | Model or participants | How often or as described | Source |
|---|---|---|---|
| Local or systemic safety concerns | 34 venous-leg-ulcer patients, topical LL-37 or placebo for four weeks | The abstract reports no identified safety concern; it gives no event list or counts — this does not mean zero events; topical findings do not establish injectable or systemic-use safety | [1] |
FAQ
Find answers to questions about LL-37 and related materials.
It is the only member of the cathelicidin family in humans: a 37-amino-acid peptide of innate immunity. It is produced by neutrophils, skin and mucous membranes — the first line of defence that meets microbes before the immune system's "heavy artillery" switches on.
Source / documentationMature LL-37 is cut from the pro-peptide hCAP18 by enzymes right at the site of inflammation. From there it works in several roles at once — antimicrobial, immune-modulating and tissue-repair — which is why it is studied both for infection defence and for wound healing.
Source / documentationHonestly: LL-37 has no validated clinical dose. Protocol sources mention a range of 100–400 mcg under the skin per day, but those are protocol reference points, not a clinical standard. Details are in the dosing guide on this page.
Source / documentationNo — it is not an antibiotic but the human body's own innate-immunity peptide: the antimicrobial action is only one of its roles alongside immune modulation and tissue repair. It is not a substitute for antibiotics in infections.
Source / documentationThere are no human clinical studies with an established dose, so an honest list of side effects cannot be compiled. A full review of the known data is in the LL-37 monograph in our wiki.
Source / documentationKeep the dry powder in a dry, dark place at a low temperature; once dissolved, store it in the refrigerator and do not freeze it again. Details are in the LL-37 guide on this page.
Source / documentationYou can buy LL-37 right on this page of our store: choose a pack size; current prices and stock are shown in the product card. We deliver across Ukraine with Nova Poshta — to a branch, a parcel locker, or by courier. Payment is by card, by crypto (with a 5% discount), or on delivery. Every vial ships with the certificate of analysis (COA) for its exact batch.
Source / documentationNo half-life for LL-37 has been published in any species. LL-37 is endogenous: it circulates bound (as hCAP-18) and is continuously replenished by neutrophils, so the half-life of an exogenous form is not separately definable. See the Dosing section for detail.
Source / documentationShare your experience
No reviews yet. Tell others what you think of this product.
LL-37 is the only member of the cathelicidin family in humans: a 37-amino-acid peptide of innate immunity. It is produced by neutrophils, skin and mucous membranes — the first line of defence that meets microbes before the immune system's "heavy artillery" switches on.
What it does: mature LL-37 is cut from the pro-peptide hCAP18 by enzymes right at the site of inflammation. From there it works in several roles at once — antimicrobial, immune-modulating and tissue-repair — which is why it is studied both for infection defence and for wound healing. Details are in the LL-37 monograph.
Honestly about the limits: LL-37 has no validated clinical dose; protocol sources mention a range of 100–400 mcg under the skin per day, but those are protocol reference points, not a clinical standard.
How it is used: the dry powder is dissolved with bacteriostatic water and injected under the skin. Reference points are in the dosing guide; the full line is in the healing and regeneration category. Another peptide on the same shelf with an immune profile is thymosin alpha-1.
Every batch is purity-tested by HPLC, and the certificate of analysis (COA) for your exact batch is in our COA archive. Keep the dry powder in a dry, dark place at a low temperature, and the dissolved solution in the refrigerator.
Buy 2, get the 3rd free
The set contains two vials of 5 mg.
10 mg: Best value · Save ≈ $6.08